CLINICAL_TRIALS
trial_result
· 2015-11-17
Clinical Trial Update: Phase 2 Study of NGM282 in Patients With Type 2 Diabetes [Phase 2]
Summary
Phase 2 study of NGM282 in patients with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NGM Biopharmaceuticals, Inc | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED